Imed Infinity Medical-Limited Partnership
Tel Aviv Stock Exchange IMED.TA
Imed Infinity Medical-Limited Partnership Gross Profit Margin for the year ending December 31, 2023
Imed Infinity Medical-Limited Partnership Gross Profit Margin is NA for the year ending December 31, 2023. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
Imed Infinity Medical-Limited Partnership Gross Profit Margin for the year ending December 31, 2022 was 100.00%, a 0.00% change year over year.
-
Imed Infinity Medical-Limited Partnership Gross Profit Margin for the year ending December 31, 2021 was 100.00%.
Key data
| Date | Gross Profit Margin | Operating Income Margin | EBT Margin | Net Income Margin |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: IMED.TA
| CEO | Mr. Itay Gal-Or |
| IPO Date | Jan. 4, 2021 |
| Location | Israel |
| Headquarters | Azrieli Tower |
| Employees | 55 |
| Sector | Industrials |
| Industries | |
Description
Imed Infinity Medical-Limited Partnership, a research and development partnership, focuses on investing in research projects and development in the medical field, primarily the digital health field. The company was incorporated in 2020 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email